The DiSCOVER Trial: Part 1
Description
Part 1 of a two-part interview featuring Chris Schelling, CEO and Founder of Acer Therapeutics, and Dr. Adrian Quartel, Chief Medical Officer of Acer Therapeutics. In this episode, Chris joins to discuss the history of Edsivo, or celiprolol, and the DiSCOVER trial, a clinical trial for Edsivo enrolling people with VEDS (Vascular Ehlers-Danlos Syndrome) in the United States.
Learn more about the DiSCOVER Trial at discoverceliprolol.com
Find more information about VEDS, including support groups and medical webinars, at https://TheVEDSMovement.org.
If you would like to share your story with VEDS on this podcast, visit
https://staying-connected.blubrry.net/contact/
Links mentioned in the episode:
DiSCOVER Trial:
VEDS Camp, hosted by the Ehlers-Danlos Society in partnership with The VEDS Movement
https://www.ehlers-danlos.com/events/veds-family-camp/
The Marfan Foundation Conference:
https://marfan.org/conference/
The Marfan Foundation Walk for Victory:
Team VEDS- Pacific Northwest Walk for Victory
https://give.marfan.org/teamvedspnw
Support
You can support this podcast by subscribing to my Patreon at https://www.patreon.com/Translucentone
Thank you to all my patrons for supporting the show, and extra thanks to my top-tier Connected Patrons:
Jon Holtom
Kacey Keegan
Adventuresinlove4Andie
Ashton Tanner
Disclaimer
The views, information and opinions in the podcast are solely those of the individuals involved and the information presented does not constitute medical or other professional advice or services. Any opinions I express in this podcast are my own, and not of my employer.
<button class="ssb_fbshare-icon" rel="nofollow" target="_blank" aria-label="Facebook Share" data-href="https://www.facebook.com/sharer/sharer.php?u=https://staying-connected.blubrry.net/2023/05/13/the-discover-trial-part-1/" onClick="javascript:window.open(this.dataset.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=600,width=600');return false;">
<svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 16 16" class="_1pbq" color="#ffffff"><path fill="#ffffff" fill-rule="evenodd" class="icon" d="M8 14H3.667C2.733 13.9 2 13.167 2 12.233V3.667A1.65 1.65 0 0 1 3.667 2h8.666A1.65 1.65 0 0 1 14 3.667v8.566c0 .934-.733 1.667-1.667 1.767H10v-3.967h1.3l.7-2.066h-2V6.933c0-.466.167-.9.867-.9H12v-1.8c.033 0-.933-.266-1.533-.266-1.267 0-2.434.7-2.467 2.133v1.867H6v2.066h2V14z"></path></svg>
Share </button>
<button class="ssb_tweet-icon" rel="nofollow" target="_blank" aria-label="Twitter Share" data-href="https://twitter.com/intent/tweet?text=The+DiSCOVER+Trial%3A+Part+1&url=https://staying-connected.blubrry.net/2023/05/13/the-discover-trial-part-1/" onClick="javascript:window.open(this.dataset.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=600,width=600');return false;">
<svg viewBox="0 0 16 14" fill="none" xmlns="http://www.w3.org/2000/svg"><path d="M4.9 0H0L5.782 7.7098L0.315 14H2.17L6.6416 8.8557L10.5 14H15.4L9.3744 5.9654L14.56 0H12.705L8.5148 4.8202L4.9 0ZM11.2 12.6L2.8 1.4H4.2L12.6 12.6H11.2Z" fill="#fff"/></svg>Post </button>
<button class="ssb_linkedin-icon" rel="nofollow" target="_blank" aria-label="LinkedIn Share" data-href="https://www.linkedin.com/sharing/share-offsite/?url=https://staying-connected.blubrry.net/2023/05/13/the-discover-trial-part-1/" onClick="javascript:window.open(this.dataset.href, '', 'menubar=no,toolbar=no,resizable=yes,scrollbars=yes,height=600,width=600');return false;" >
<svg version="1.1" id="Layer_1" xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" x="0px" y="0px" width="15px" height="14.1px" viewBox="-301.4 387.5 15 14.1" enable-background="new -301.4 387.5 15 14.1" xml:space="preserve"> <g id="XMLID_398_"> <path id="XMLID_399_" fill="#FFFFFF" d="M-296.2,401.6c0-3.2,0-6.3,0-9.5h0.1c1,0,2,0,2.9,0c0.1,0,0.1,0,0.1,0.1c0,0.4,0,0.8,0,1.2 c0.1-0.1,0.2-0.3,0.3-0.4c0.5-0.7,1.2-1,2.1-1.1c0.8-0.1,1.5,0,2.2,0.3c0.7,0.4,1.2,0.8,1.5,1.4c0.4,0.8,0.6,1.7,0.6,2.5 c0,1.8,0,3.6,0,5.4v0.1c-1.1,0-2.1,0-3.2,0c0-0.1,0-0.1,0-0.2c0-1.6,0-3.2,0-4.8c0-0.4,0-0.8-0.2-1.2c-0.2-0.7-0.8-1-1.6-1 c-0.8,0.1-1.3,0.5-1.6,1.2c-0.1,0.2-0.1,0.5-0.1,0.8c0,1.7,0,3.4,0,5.1c0,0.2,0,0.2-0.2,0.2c-1,0-1.9,0-2.9,0 C-296.1,401.6-296.2,401.6-296.2,401.6z"/> <path id="XMLID_400_" fill="#FFFFFF" d="M-298,401.6L-298,401.6c-1.1,0-2.1,0-3,0c-0.1,0-0.1,0-0.1-0.1c0-3.1,0-6.1,0-9.2 c0-0.1,0-0.1,0.1-0.1c1,0,2,0,2.9,0h0.1C-298,395.3-298,398.5-298,401.6z"/> <path id="XMLID_401_" fill="#FFFFFF" d="M-299.6,390.9c-0.7-0.1-1.2-0.3-1.6-0.8c-0.5-0.8-0.2-2.1,1-2.4c0.6-0.2,1.2-0.1,1.8,0.2 c0.5,0.4,0.7,0.9,0.6,1.5c-0.1,0.7-0.5,1.1-1.1,1.3C-299.1,390.8-299.4,390.8-299.6,390.9L-299.6,390.9z"/> </g> </svg>
Share </button>
United States
